• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维持性血液透析患者焦虑抑郁影响因素分析及其与 BDNF、NT-3 和 5-HT 水平的相关性。

Analysis of influencing factors of anxiety and depression in maintenance hemodialysis patients and its correlation with BDNF, NT-3 and 5-HT levels.

机构信息

Department of Hemodialysis Center, Second Affiliated Hospital of Nantong University (First People's Hospital), Nantong, China.

International Guests Ward, Second Affiliated Hospital of Nantong University (First People's Hospital), Nantong, China.

出版信息

PeerJ. 2023 Sep 21;11:e16068. doi: 10.7717/peerj.16068. eCollection 2023.

DOI:10.7717/peerj.16068
PMID:37750080
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10518163/
Abstract

OBJECTIVE

The aim of this study is to examine the factors that contribute to anxiety and depression in individuals undergoing maintenance hemodialysis (MHD), as well as their association with serum levels of brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and serotonin (5-HT).

METHODS

In May 2020 and June 2022, 120 MHD patients who received MDH treatment at our hospital were enrolled. The control group was composed of 60 healthy adults (>18) who completed the physical examination at the same time. The serum levels of BDNF, NT-3, and 5-HT in patients and clinical data of MHD patients with different degrees of anxiety and depression were compared. The Pearson correlation was used to evaluate the correlation between anxiety and depression scores and serum BDNF, NT-3,5-HT levels in patients with MHD. Multivariate analysis was employed to analyze the risk factors of anxiety and depression in MHD patients.

RESULTS

The incidence of anxiety and depression in 120 MHD patients was 34.17% (41/120) and 64.17% (77/120), respectively. The levels of serum NT-3 and 5-HT in the anxiety group were higher than those in the non-anxiety and control group, and the levels of serum NT-3 in the non-anxiety group were higher than those in the control group ( < 0.05). The levels of serum BDNF, NT-3 and 5-HT in the depressed group were higher than those in the non-depressed group and control group, and the levels of serum NT-3 in the non-depressed group were higher than those in the control group ( < 0.05). SAS score was positively correlated with serum NT-3 and 5-HT levels, while the SDS score was negatively correlated with serum BDNF and positively correlated with serum NT-3 and 5-HT levels. Female, rural household registration, and restless leg syndrome were independent risk variables for anxiety in patients with MHD ( < 0.05). Rural household registration, economic deterioration, fatigue, insomnia, and vascular pain were independent variables of depression risk in patients with MHD.

CONCLUSION

Anxiety and depression in patients with MHD are closely related to the levels of serum BDNF, NT-3, and 5-HT. Female, rural household registration, more than eight dialysis times/month, insomnia, and restless leg syndrome are the risk factors for anxiety in patients with MHD. Rural household registration, economic deterioration, fatigue, insomnia, and vascular pain are the risk factors for depression in patients with MHD. The clinical implication of these findings suggests that these indexes may perhaps serve as biological indicators of anxiety and depression amongst patients undergoing MHD. Such investigation can hence contribute to early detection, monitoring, and potentially enable the depiction of novel therapeutic strategies for managing these adverse states.

摘要

目的

本研究旨在探讨接受维持性血液透析(MHD)患者焦虑和抑郁的相关因素,以及这些因素与脑源性神经营养因子(BDNF)、神经营养因子-3(NT-3)和 5-羟色胺(5-HT)血清水平的关系。

方法

2020 年 5 月至 2022 年 6 月,我院收治的 120 例 MHD 患者纳入本研究。对照组由同时完成体检的 60 名健康成年人(>18 岁)组成。比较患者和不同程度焦虑和抑郁的 MHD 患者的 BDNF、NT-3 和 5-HT 血清水平及临床资料。采用 Pearson 相关分析评估 MHD 患者焦虑和抑郁评分与血清 BDNF、NT-3、5-HT 水平的相关性。采用多因素分析分析 MHD 患者焦虑和抑郁的危险因素。

结果

120 例 MHD 患者焦虑发生率为 34.17%(41/120),抑郁发生率为 64.17%(77/120)。焦虑组血清 NT-3 和 5-HT 水平高于非焦虑组和对照组,非焦虑组血清 NT-3 水平高于对照组(<0.05)。抑郁组血清 BDNF、NT-3 和 5-HT 水平高于非抑郁组和对照组,非抑郁组血清 NT-3 水平高于对照组(<0.05)。SAS 评分与血清 NT-3 和 5-HT 水平呈正相关,SDS 评分与血清 BDNF 呈负相关,与血清 NT-3 和 5-HT 呈正相关。女性、农村户籍、不安腿综合征是 MHD 患者焦虑的独立危险因素(<0.05)。农村户籍、经济恶化、乏力、失眠、血管性疼痛是 MHD 患者抑郁的独立危险因素。

结论

MHD 患者的焦虑和抑郁与血清 BDNF、NT-3 和 5-HT 水平密切相关。女性、农村户籍、每月透析次数>8 次、失眠、不安腿综合征是 MHD 患者焦虑的危险因素。农村户籍、经济恶化、乏力、失眠、血管性疼痛是 MHD 患者抑郁的危险因素。这些发现的临床意义表明,这些指标可能是 MHD 患者焦虑和抑郁的生物学指标。这种研究可以帮助早期发现、监测,并可能为管理这些不良状态提供新的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf1/10518163/51be2e283572/peerj-11-16068-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf1/10518163/bc6155fd7bd2/peerj-11-16068-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf1/10518163/7187e99750be/peerj-11-16068-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf1/10518163/d215ea779696/peerj-11-16068-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf1/10518163/51be2e283572/peerj-11-16068-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf1/10518163/bc6155fd7bd2/peerj-11-16068-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf1/10518163/7187e99750be/peerj-11-16068-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf1/10518163/d215ea779696/peerj-11-16068-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/edf1/10518163/51be2e283572/peerj-11-16068-g004.jpg

相似文献

1
Analysis of influencing factors of anxiety and depression in maintenance hemodialysis patients and its correlation with BDNF, NT-3 and 5-HT levels.维持性血液透析患者焦虑抑郁影响因素分析及其与 BDNF、NT-3 和 5-HT 水平的相关性。
PeerJ. 2023 Sep 21;11:e16068. doi: 10.7717/peerj.16068. eCollection 2023.
2
Serum brain-derived neurotrophic factor reflects the lower inflammation, lipid level, and major adverse cardiac and cerebrovascular events risk in maintenance hemodialysis patients.血清脑源性神经营养因子反映了维持性血液透析患者较低的炎症、脂质水平以及主要不良心脏和脑血管事件风险。
Scand J Clin Lab Invest. 2023 Jul;83(4):264-270. doi: 10.1080/00365513.2023.2221864. Epub 2023 Jun 21.
3
Cerebral blood flow changes in maintenance hemodialysis patients with restless legs syndrome and their clinical significance:a cross-sectional case-control study.维持性血液透析患者不安腿综合征的脑血流变化及其临床意义:一项横断面病例对照研究。
BMC Neurol. 2024 Apr 16;24(1):128. doi: 10.1186/s12883-024-03636-w.
4
Restless-legs syndrome and insomnia in hemodialysis patients.血液透析患者的不安腿综合征与失眠
Ren Fail. 2016;38(2):194-7. doi: 10.3109/0886022X.2015.1111118. Epub 2015 Nov 10.
5
Relation between anxiety, depression, and physical activity and performance in maintenance hemodialysis patients.维持性血液透析患者的焦虑、抑郁与体力活动及表现的关系。
J Ren Nutr. 2014 Jul;24(4):252-60. doi: 10.1053/j.jrn.2014.03.002. Epub 2014 Apr 29.
6
Restless legs syndrome in maintenance hemodialysis patients: an epidemiologic survey in Hefei.维持性血液透析患者的不宁腿综合征:合肥地区的一项流行病学调查
Int Urol Nephrol. 2017 Jul;49(7):1267-1272. doi: 10.1007/s11255-017-1573-3. Epub 2017 Mar 28.
7
Physical activity and self-reported symptoms of insomnia, restless legs syndrome, and depression: the comprehensive dialysis study.身体活动与失眠、不宁腿综合征及抑郁的自我报告症状:综合透析研究
Hemodial Int. 2013 Jan;17(1):50-8. doi: 10.1111/j.1542-4758.2012.00726.x. Epub 2012 Jul 20.
8
Effect of Renal Transplantation in Restless Legs Syndrome.肾移植对不宁腿综合征的影响。
Exp Clin Transplant. 2016 Feb;14(1):45-9. doi: 10.6002/ect.2014.0163. Epub 2014 Dec 11.
9
Analysis of the prevalence and influencing factors of depression and anxiety among maintenance dialysis patients during the COVID-19 pandemic.新冠疫情期间维持性透析患者抑郁和焦虑的患病率及影响因素分析
Int Urol Nephrol. 2021 Jul;53(7):1453-1461. doi: 10.1007/s11255-021-02791-0. Epub 2021 Mar 6.
10
Paroxetine Effect on Nerve Growth Factor, Human Neurotrophin-4, Brain-Derived Neurotrophic Factor Levels in Post-stroke Depression.帕罗西汀对卒中后抑郁患者神经生长因子、人神经营养因子-4、脑源性神经营养因子水平的影响。
Mol Neurobiol. 2024 Oct;61(10):7890-7897. doi: 10.1007/s12035-024-04084-w. Epub 2024 Mar 5.

引用本文的文献

1
Correlation between anxiety, depression, self-perceived burden, and psychological resilience in patients with chronic renal failure on maintenance hemodialysis.维持性血液透析慢性肾衰竭患者焦虑、抑郁、自我感知负担与心理弹性的相关性
World J Psychiatry. 2025 Jul 19;15(7):103850. doi: 10.5498/wjp.v15.i7.103850.
2
Exploring health challenges and coping strategies in young patients undergoing maintenance hemodialysis: a qualitative study.探索维持性血液透析年轻患者的健康挑战及应对策略:一项定性研究
BMC Nephrol. 2025 Jul 11;26(1):378. doi: 10.1186/s12882-025-04320-y.
3
Plasma brain-derived neurotrophic factor before hemodialysis reduces the risk of depression in patients with chronic renal failure.

本文引用的文献

1
Prevalence of depression and anxiety and their predictors among patients undergoing maintenance hemodialysis in Northern China: a cross-sectional study.中国北方维持性血液透析患者抑郁和焦虑的患病率及其预测因素:一项横断面研究。
Ren Fail. 2022 Dec;44(1):933-944. doi: 10.1080/0886022X.2022.2077761.
2
Mental health status and quality of life in patients with end-stage renal disease undergoing maintenance hemodialysis.终末期肾病维持性血液透析患者的心理健康状况和生活质量。
Ann Palliat Med. 2021 Jun;10(6):6112-6121. doi: 10.21037/apm-20-2211. Epub 2021 May 26.
3
Effect of Aerobic Exercise on Dialysis-Related Symptoms in Individuals Undergoing Maintenance Hemodialysis: A Systematic Review and Meta-Analysis of Clinical Trials.
血液透析前血浆脑源性神经营养因子可降低慢性肾衰竭患者的抑郁风险。
Ren Fail. 2025 Dec;47(1):2463561. doi: 10.1080/0886022X.2025.2463561. Epub 2025 Feb 17.
4
Analysis of risk factors for depression in peritoneal dialysis patients and establishment of a risk nomogram model.腹膜透析患者抑郁风险因素分析及风险列线图模型的建立
Clinics (Sao Paulo). 2025 Feb 13;80:100600. doi: 10.1016/j.clinsp.2025.100600. eCollection 2025.
5
Effect of mental state on sleep quality in patients receiving maintenance hemodialysis: A multiple mediation model of hope and family function.精神状态对维持性血液透析患者睡眠质量的影响:希望和家庭功能的多重中介模型。
Medicine (Baltimore). 2024 Nov 8;103(45):e40503. doi: 10.1097/MD.0000000000040503.
6
A comparison of ondansetron in preventing postoperative nausea and vomiting for patients with or without preoperative anxiety with painless egg retrieval: a prospective, randomized, controlled trial.昂丹司琼预防有无术前焦虑的无痛取卵患者术后恶心呕吐的比较:一项前瞻性、随机、对照试验。
Gland Surg. 2024 Aug 31;13(8):1522-1534. doi: 10.21037/gs-24-175. Epub 2024 Aug 12.
7
Development and Validation of a Nomogram Model for Accurately Predicting Depression in Maintenance Hemodialysis Patients: A Multicenter Cross-Sectional Study in China.用于准确预测维持性血液透析患者抑郁的列线图模型的开发与验证:一项中国多中心横断面研究
Risk Manag Healthc Policy. 2024 Sep 3;17:2111-2123. doi: 10.2147/RMHP.S456499. eCollection 2024.
有氧运动对维持性血液透析患者透析相关症状的影响:临床试验的系统评价和荟萃分析。
Clin J Am Soc Nephrol. 2021 Apr 7;16(4):560-574. doi: 10.2215/CJN.15080920. Epub 2021 Mar 25.
4
Analysis of the prevalence and influencing factors of depression and anxiety among maintenance dialysis patients during the COVID-19 pandemic.新冠疫情期间维持性透析患者抑郁和焦虑的患病率及影响因素分析
Int Urol Nephrol. 2021 Jul;53(7):1453-1461. doi: 10.1007/s11255-021-02791-0. Epub 2021 Mar 6.
5
Prevalence of depression, anxiety, and their associations among end-stage renal disease patients on maintenance hemodialysis: a multi-center population-based study.维持性血液透析终末期肾病患者的抑郁、焦虑患病率及其相关性:一项多中心基于人群的研究。
Psychol Health Med. 2021 Oct;26(9):1134-1142. doi: 10.1080/13548506.2020.1852476. Epub 2020 Nov 29.
6
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders.大麻二酚:治疗焦虑、抑郁和精神障碍的新选择。
Biomolecules. 2020 Nov 19;10(11):1575. doi: 10.3390/biom10111575.
7
Is neurotrophin-3 (NT-3): a potential therapeutic target for depression and anxiety?神经生长因子-3(NT-3):抑郁症和焦虑症的潜在治疗靶点?
Expert Opin Ther Targets. 2020 Dec;24(12):1225-1238. doi: 10.1080/14728222.2020.1846720. Epub 2020 Nov 26.
8
Patient-reported outcomes in maintenance hemodialysis: a cross-sectional, multicenter study.维持性血液透析患者报告结局的横断面、多中心研究。
Qual Life Res. 2020 Sep;29(9):2345-2354. doi: 10.1007/s11136-020-02508-3. Epub 2020 Apr 30.
9
Knockdown of miR-124 Reduces Depression-like Behavior by Targeting CREB1 and BDNF.miR-124 通过靶向 CREB1 和 BDNF 减少抑郁样行为。
Curr Neurovasc Res. 2020;17(2):196-203. doi: 10.2174/1567202617666200319141755.
10
Norms for Zung's Self-rating Anxiety Scale.Zung 自评焦虑量表的常模。
BMC Psychiatry. 2020 Feb 28;20(1):90. doi: 10.1186/s12888-019-2427-6.